Srovnal Josef M.D., Ph.D.
Journals
Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival.
Translational Lung Cancer Research.
2022,
11(10),
2040-2050,
ISSN: 2218-6751,
PMID: 36386452,
Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma Recurrence.
Neurosurgery.
2022,
91(2),
360-369,
ISSN: 0148-396X,
PMID: 35551164,
Books & book chapters
Detekce nádorových biomarkerů v molekulárně biologické laboratoři,
1. vyd,
Olomouc,
Univerzita Palackého v Olomouci,
2012,
144 s,
Dedication: MOLONKOL CZ.1.07/2.3.00/09.0089,
ISBN: 978-80-244-3002-7,
Open positions
Project: | Liquid biopsies in experimental and clinical oncology |
---|---|
Supervisors: | Srovnal Josef M.D., Ph.D. |
Available: | 2 |
Intended for: | Doctoral training |
Summary: | 2 places in full-time or combined form of study |
Project: | New prognostic and predictive factors in solid tumors |
---|---|
Supervisors: | Srovnal Josef M.D., Ph.D. |
Available: | 2 |
Intended for: | Doctoral training |
Summary: | 2 places in full-time or combined form of study |
Project: | Identification of molecular targets and mechanisms of resistance in antitumor drugs |
---|---|
Supervisors: | Srovnal Josef M.D., Ph.D., Hajdúch Marián M.D., Ph.D. |
Available: | 2 |
Intended for: | Doctoral training |
Summary: | 2 places in full-time study |
Project: | Diagnosis and treatment of rare diseases |
---|---|
Supervisors: | Hajdúch Marián M.D., Ph.D., Srovnal Josef M.D., Ph.D. |
Available: | 2 |
Intended for: | Doctoral training |
Summary: | 2 places in full-time study |